NMRA-GRIN2B

N/A

Report date: 2023/05/22 10:20:16
NME

Base Information

Drug NameNMRA-GRIN2B
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeumora Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeumora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A